These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34346523)
21. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models. Wheeler SE; Shi H; Lin F; Dasari S; Bednash J; Thorne S; Watkins S; Joshi R; Thomas SM Head Neck; 2014 Mar; 36(3):385-92. PubMed ID: 23728942 [TBL] [Abstract][Full Text] [Related]
22. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells. Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144 [TBL] [Abstract][Full Text] [Related]
23. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc. Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504 [TBL] [Abstract][Full Text] [Related]
24. IL-1β Induces Fascin Expression and Increases Cancer Invasion. Lee MK; Park JH; Gi SH; Hwang YS Anticancer Res; 2018 Nov; 38(11):6127-6132. PubMed ID: 30396928 [TBL] [Abstract][Full Text] [Related]
25. Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer. Haughton PD; Haakma W; Chalkiadakis T; Breimer GE; Driehuis E; Clevers H; Willems S; Prekovic S; Derksen PWB Oncogene; 2024 Aug; 43(32):2463-2474. PubMed ID: 38942893 [TBL] [Abstract][Full Text] [Related]
26. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847 [TBL] [Abstract][Full Text] [Related]
27. Catulin Based Reporter System to Track and Characterize the Population of Invasive Cancer Cells in the Head and Neck Squamous Cell Carcinoma. Karpińska K; Gielata M; Gwiazdowska A; Boryń Ł; Kobielak A Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008571 [TBL] [Abstract][Full Text] [Related]
28. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis. Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma. Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma. Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374 [TBL] [Abstract][Full Text] [Related]
31. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
32. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis. Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826 [TBL] [Abstract][Full Text] [Related]
33. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy. Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387 [No Abstract] [Full Text] [Related]
34. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580 [TBL] [Abstract][Full Text] [Related]
35. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma. Li J; Chen W; Luo L; Liao L; Deng X; Wang Y Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597 [TBL] [Abstract][Full Text] [Related]
36. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers. Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900 [TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor-induced COX-2 regulates metastasis of head and neck squamous cell carcinoma through upregulation of angiopoietin-like 4. Chiang KH; Shieh JM; Shen CJ; Chang TW; Wu PT; Hsu JY; Tsai JP; Chang WC; Chen BK Cancer Sci; 2020 Jun; 111(6):2004-2015. PubMed ID: 32227417 [TBL] [Abstract][Full Text] [Related]
38. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. Kang S; Elf S; Lythgoe K; Hitosugi T; Taunton J; Zhou W; Xiong L; Wang D; Muller S; Fan S; Sun SY; Marcus AI; Gu TL; Polakiewicz RD; Chen ZG; Khuri FR; Shin DM; Chen J J Clin Invest; 2010 Apr; 120(4):1165-77. PubMed ID: 20234090 [TBL] [Abstract][Full Text] [Related]
39. Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma. Moon JH; Lee SH; Lim YC Clin Exp Metastasis; 2021 Apr; 38(2):163-174. PubMed ID: 33630219 [TBL] [Abstract][Full Text] [Related]
40. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma. Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]